Andrew Kellett

Andrew Kellett serves as the Chief Financial Officer at Biotage since September 2023, overseeing financial operations for a public company specializing in separations technology. Concurrently, Kellett holds the CFO position at Astrea Bioseparations Ltd, a biotechnology company focused on chromatography solutions, since April 2022. Kellett has extensive experience in financial leadership roles, including previous positions as CFO at Technetix, Cmed Group, and Finance Director at Genetix and Quest Diagnostics. Notable achievements include successful acquisitions, business transformations, and significant fundraising efforts across multiple organizations. Kellett holds a degree in Economics from Aberystwyth University.